We are live on ! Find out more
RBC

Roble Belko & Company Portfolio holdings

AUM $925M
1-Year Est. Return 19.7%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+19.7%
3 Year Est. Return
+53.27%
5 Year Est. Return
+47.85%
10 Year Est. Return
+149.75%
AUM
$245M
AUM Growth
+$19.1M
Cap. Flow
+$9.86M
Cap. Flow %
4.03%
Top 10 Hldgs %
62.68%
Holding
339
New
38
Increased
42
Reduced
26
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QRVO icon
151
Qorvo
QRVO
$10.3B
$27K 0.01%
+410
New +$29.9K
ETY icon
152
Eaton Vance Tax-Managed Diversified Equity Income Fund
ETY
$2.23B
$26K 0.01%
2,168
IGA
153
Voya Global Advantage and Premium Opportunity Fund
IGA
$164M
$26K 0.01%
2,310
ABBV icon
154
AbbVie
ABBV
$466B
$24K 0.01%
243
ETN icon
155
Eaton
ETN
$165B
$24K 0.01%
300
REGN icon
156
Regeneron Pharmaceuticals
REGN
$80.8B
$24K 0.01%
+65
New +$26.3K
STLD icon
157
Steel Dynamics
STLD
$33.7B
$24K 0.01%
550
BOE icon
158
BlackRock Enhanced Global Dividend Trust
BOE
$678M
$23K 0.01%
1,820
DIS icon
159
Walt Disney
DIS
$177B
$23K 0.01%
214
BPK
160
DELISTED
Blackrock Muni 2018 Term Tr
BPK
$23K 0.01%
1,554
BDX icon
161
Becton Dickinson
BDX
$49.3B
$22K 0.01%
107
CVS icon
162
CVS Health
CVS
$114B
$22K 0.01%
300
IJR icon
163
iShares Core S&P Small-Cap ETF
IJR
$105B
$22K 0.01%
284
NLSN
164
DELISTED
Nielsen Holdings plc
NLSN
$22K 0.01%
+610
New +$23.2K
CELG
165
DELISTED
Celgene Corp
CELG
$22K 0.01%
211
+144
+215% +$16.2K
GLD icon
166
SPDR Gold Trust
GLD
$148B
$21K 0.01%
172
HDV
167
iShares Core High Dividend ETF
HDV
$15.2B
$21K 0.01%
1,190
VGT icon
168
Vanguard Information Technology ETF
VGT
$150B
$21K 0.01%
1,000
RDS.B
169
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$21K 0.01%
+304
New +$19.7K
HBAN icon
170
Huntington Bancshares
HBAN
$32.1B
$20K 0.01%
1,355
ESRX
171
DELISTED
Express Scripts Holding Company
ESRX
$20K 0.01%
264
+215
+439% +$13.8K
BA icon
172
Boeing
BA
$157B
$19K 0.01%
65
CTSH icon
173
Cognizant
CTSH
$27B
$19K 0.01%
270
KMT icon
174
Kennametal
KMT
$2.27B
$19K 0.01%
400
AZN icon
175
AstraZeneca
AZN
$258B
$18K 0.01%
260

Similar funds

Roble Belko & Company's Q4 2017 Portfolio in Review

As of Q4 2017, Roble Belko & Company held 339 positions worth $245M, up 8.5% from $226M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Roble Belko & Company deployed $9.86M of net new capital in Q4 2017, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Vanguard Short-Term Corporate Bond ETF: 6,721 shares worth $533K.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, down from 96% a quarter earlier, followed by Real Estate and Technology.

On the sell side, the largest reduction was Xtrackers MSCI EAFE Hedged Equity ETF, an estimated $4.8M trimmed.

  • Roble Belko & Company's largest Q4 2017 buy was Vanguard Short-Term Corporate Bond ETF: 6,721 shares worth $533K.
  • Roble Belko & Company added most to iShares Short Maturity Bond ETF in Q4 2017, an estimated $5.09M increase.
  • Roble Belko & Company's biggest Q4 2017 reduction was Xtrackers MSCI EAFE Hedged Equity ETF, cutting an estimated $4.8M.
  • Roble Belko & Company fully exited iShares Core S&P US Growth ETF in Q4 2017, selling an estimated $453K.
  • Roble Belko & Company's ten largest holdings make up 63% of its $245M portfolio in Q4 2017.
  • Roble Belko & Company opened 38 new positions and closed 12 in Q4 2017.
  • Roble Belko & Company's portfolio value rose 8.5% quarter-over-quarter to $245M.

Based on Roble Belko & Company's 13F filing for Q4 2017, filed 30 Jan 2018.